Permits prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.
Sponsored By: Andrea Katz (Democratic), Vincent M. Kearney (Democratic), Marisa Sweeney (Democratic)
Introduced
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & Cosponsors
Sponsors
Andrea Katz
Democratic • House
Vincent M. Kearney
Democratic • House
Marisa Sweeney
Democratic • House
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
No roll call votes available for this bill.
Actions Timeline
Introduced, 1st Reading in Assembly, Referred to Assembly Health Committee
5/4/2026House
Bill Text
As Introduced
5/5/2026
Related Bills
A4844 — Establishes "Targeted Midwifery Workforce Development Act"; appropriates $12 million.
A4836 — Exempts certain portable solar generation devices from interconnection, net metering, and other requirements; requires DCA to amend or supplement State Uniform Construction Code concerning use of portable solar generation devices.
A4867 — Establishes toll free helpline for first responders, health care workers, and other frontline workers experiencing post-traumatic stress disorder.
A4871 — Allows gross income tax deduction for charitable contributions made to nonprofit entities supported by State funds or subsides.
A4856 — Expands liability of certain individuals associated with limited liability companies and other commercial entities, when acting as residential landlord.
A4872 — "End the Toll Trap Act"; concerns toll violations and related administrative fees; establishes "New York and New Jersey Toll and Fee Reduction Task Force."